Eledon Pharmaceuticals, Inc. (ELDN) stock
Close on Nov 13, 2026Market cap $171.87MP/E –Yield –
Earnings
Eledon Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Eledon Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 18, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026after the close | – | – | -$0.03 | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 13, 2026during market hours | – | – | -$0.27 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 13, 2026during market hours | – | – | -$0.33 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 19, 2026during market hours | – | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 14, 2025during market hours | – | – | -$0.21 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025during market hours | – | – | -$0.13 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025during market hours | – | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 20, 2025during market hours | – | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024during market hours | – | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024during market hours | – | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024during market hours | – | – | -$0.34 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024during market hours | – | – | -$0.32 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023during market hours | – | – | -$0.35 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | – | – | -$0.40 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023during market hours | – | – | -$0.75 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 30, 2023during market hours | – | – | $4.09 | $0.68 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022during market hours | – | – | -$0.73 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022during market hours | – | – | -$0.65 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022during market hours | – | – | -$0.69 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 24, 2022during market hours | – | – | -$0.59 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | – | – | -$0.66 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 13, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 15, 2020before the open | – | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 17, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Eledon Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Eledon Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Eledon Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial ResultsResults
- Results
- Results
- Update
- Results
- Results
- Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial ResultsResults
- Update
- Update
- Results
- Results
See a number that looks wrong?